Cargando…
Addition of cyclosporine-A (Neoral(®)) in patients on anti-TNF and methotrexate therapy improves disease activity: an open-label, pilot study
Autores principales: | Sidiropoulos, P, Siakka, P, Mamoulaki, M, Kouroumali, H, Kritikos, H, Boumpas, DT |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2833772/ http://dx.doi.org/10.1186/ar1131 |
Ejemplares similares
-
Effects of anti-TNF therapy on endothelial function and intima–media thickness of common carotid artery in patients with rheumatoid arthritis
por: Siakka, P, et al.
Publicado: (2004) -
Expression of programmed death (PD)-1 and PD-1 ligands (PD-L1, PD-L2) in peripheral blood mononuclear cells of patients with systemic lupus erythematosus
por: Bertsias, G, et al.
Publicado: (2005) -
Adjustment in anti-TNF therapy after initial response: long-term follow-up in patients with rheumatoid arthritis
por: Sidiropoulos, P, et al.
Publicado: (2003) -
Clinical evaluation of efficacy and safety of cyclosporine (Imusporin) in renal transplant patients with stable graft function maintained on neoral or bioral
por: Jha, Mrigank S., et al.
Publicado: (2007) -
TLR-9, but not TLR-2, TLR-3 and TLR-4, is upregulated on peripheral blood mononuclear cells of patients with active systemic lupus erythematosus
por: Papadimitraki, ED, et al.
Publicado: (2005)